Prescription Benefits

CMS Proposed Changes to Prescription Benefits

[vc_row][vc_column][rev_slider_vc alias="change-to-rx-benefits"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]At the end of last month, CMS proposed a rule to change some key components of prescription coverage for Medicare Part D and Medicare Advantage beneficiaries. The key change revolves around the six protected classes: antidepressants, antipsychotics, anticonvulsants, immunosuppressants for transplant rejections, antiretrovirals and antineoplastics (typically cancer treatment drugs). The six protected classes acknowledge that beneficiaries may need access to more than one drug in a particular therapeutic class. The...

Donna White
Share
CMS Final Rule 2019

CMS Final Rule 2019

[vc_row][vc_column][rev_slider_vc alias="cms-2019-final-rule"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]November sees the publishing of Medicare’s final rules for 2019. It has allowed for sweeping changes to Telehealth, provider reimbursement and Quality reporting. Medicare will now reimburse for patients connecting with their provider in a telecommute session to determine if an in-office visit is necessary. Changes made to the Quality Payment Program (QPP) will shift the focus from paperwork to positively impacting health outcomes. The key focus is on sharing...

Donna White
Share
Prescription Benefits

Controlling Prescription Drug Costs

[vc_row][vc_column][rev_slider_vc alias="rx-costs"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]Last week, the Trump administration announced the first mandatory CMS pay model to reign in the cost of prescription drugs. This proposal from the Department of Health & Human Services is a two-step process. One would be to decrease drug rates paid by Medicare Part B by indexing them to be in line with the lower prices paid by other developed nations. The other would be to change the...

Donna White
Share